CNS 2016_Brochure-ilovepdf-compressed

CNS 2016

conferenceseries.comBrochure

http://cns.conferenceseries.com/

Conference Secretariat2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USA

Phone: + 1-888-843-8169, Fax: +1-650-618-1417, Toll Free: +1-800-216-649Email: [email protected]

Dubai, UAE December 05-07, 2016

2nd International Conference on

Central Nervous System Disorders and Therapeutics

CNS 2016

conferenceseries.com

OMICS International welcomes you to attend the 2nd International Conference on Central Nervous System Disorders and Therapeutics during December 05-07, 2016 at Dubai, UAE.

We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Neurology.

CNS 2016 anticipates more than 300 participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates include Editorial Board Members of related OMICS International Journals.

This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

The intending participants can confirm their participation by registering for the conference along with your colleagues. Avail the delegate early bird offer.

The main theme of the conference is “Accelerate the Diagnosis, Prevention & Management of CNS disorders”.

Regards,CNS 2016 Organizing Committee

Invitation


CNS 2016


Adam KaplinMontel Williams MS Foundation USA

Aguinaldo Pereira CatanoceUniversity Hospital Technical Puc Campinas, Brazil

Ali SavasAnkara University, Turkey

Arif KhanAmerican Centre for Psychiatry and Neurology, UAE

Brian J CummingsUniversity of California, USA

David BonovichSan Ramon Regional Medical Center, Pacific Rim Neurovascular Associates, Sutter Health, USA

Dionisio Figueiredo LopesHospital Urgencia Otavio Lage Brazil

Fabio BiancoNeuro-Zone, Sanipedia Ltd, Italy

Hiroyuki NakaseNara Medical University, Japan

Huma SheikhMt Sinai Beth Israel, USA

Joanna B StrosznajderMt Sinai Beth Israel, Poland

Kate McLellanKM Clinical Research Group, USA

Lilianne R Mujica ParodiStony Brook University School of Medicine, USA

Maria A NagelUniversity of Colorado School of Medicine, USA

Martin J StranskyYale University, USA

Mohamed FarahJohns Hopkins University, USA

Roberto Villa FedericoUniversity of Pavia, Italy

Rwoof A ReshiUniversity of Minnesota, USA

Song Guo ZhengPenn State University Hershey Col-lege of Medicine, USA

TANG Wai KwongThe Chinese University of Hong-kong, China

Tissa WijeratneWestern Health, Australia

Wissam BaradaAmerican Center for Psychiatry and Neurology, UAE

Organizing Committee Members

CNS 2016



Tentative Speakers

Nataiila Melynk, National Medical University, Ukraine

Suad Alanzi, Curtin University, Kuwait

Dionisio Figueiredo Lopes, Hospital de Urgencia Otavio Lage, Brazil

Fatima Laraba-Djebari, USTHB, Algeria

Elena Solntseva, Lomonosov Moscow State University, Russian Federation

Arash Khameneh Bgheri, Mashhad University of Science, Iran

Deeba Noreen Baig, Forman Christian College University, Pakistan

Nahla Nagy, Ain Shams University Egypt

Sina Salehi, Shiraz University of Medical Sciences, Iran

Ebthial Eltyeb, Omdurman Islamic Universit, Sudhan

Rwoof Reshi, University of Minnesota, USA

Yasamin Ghazvini Kor, Mafraq Hospital, UAE

Swarupa Mitra, Rajiv Gandhi cancer Institute & Research Centre, India

Ksenija Fumić, University Hospital Center Zagreb, Croatia

Barbora Slavikova, Institute of Organic Chemistry and Biochemistry,

Academy of Sciences, Czech Republic

Hana Chodounska, Institute of Organic Chemistry and Biochemistry,

Academy of Sciences, Czech Republic

Eva Kudova, Institute of Organic Chemistry and Biochemistry, Acad-

emy of Sciences, Czech Republic

Hiroyuki Nakase, Nara Medical University, Japan

Chinnu Selim, Central Food Technological Research Institute, India

Yafa Alshamlan, Saudi Arabia

Olga Kopach, UCL Institute of Neurology, UK

Seema Lalani, Baylor College of Medicine, USA

Joanna Strosznajder, Mossakowski Medical Research Centre, Polish

Academy of Sciences, Poland

Song Guo Zheng, Penn State University Milton. S. Hershey Medical

Center, USA

Abdolreza Esnaashari, Akershus University Hospital, Norway

Edward Kachur, McMaster University Faculty of Health Sciences, Canada

Nicola Salvatore Orefice, Federico II University, France

Lu Lu, Tianjin Medical University , China

Yash Patel, McMaster University, Canada

Angel Horcajadas, Vithas Hospital Health, Spian

Eileen Thomas, University of Cape Town, South Africa

Arpad Szallasi, Drexel University College of Medicine, USA

Liam Chen, Johns Hopkins University, USA

Brian J Cummings, University of California, USA

Ahmed Al Jishi, McMaster University Health Center, Canada

Philippe Bergonzo, French Atomic Energy Commission, France

Ma Xun Tai, Southwest Medical University, China

Svetlana Tomic, University of Josip Juraj Strossmayer in Osijek, Croatia

Jose Luis Acha Sanchez, National University of San Marcos, Peru

Hassan Barnawi, Taibah Medical College, Saudi Arabia

Nadia Hafizi Rastabi, Tehran University of Medical Sciences, Iran

Aguinaldo P. Catanoce, Pontificia Catholica University of Campinas,

Brazil

Emmanuel Iwuozo, Federal Medical Centre, Nigeria

Shuo Wang, California Institute of Technology, USA

Sophia Bakhtadze, Tbilisi State Medical University, Georgia

Wudassie Melak, Jimma University, Ethiopia

Cao Fei, Huazhong University of Science and Technology, China

Ajay Bajaj, Wockhardt Hospitals LTd., India

Ali Savas, Ankara University, Turkey

Diane Robert Stoler, Harvard University, USA

CNS 2016


11th Global Dermatologists AnnualMeeting Nov 14-16, 2016 Dubai, UAE

15th Global Diabetes Summit and Medicare Expo Nov 14-16, 2016 Dubai, UAE

9th Global Obesity Meeting Nov 14-15, 2016 Dubai, UAE

5th Global Respiratory and Pulmonologist Annual Meeting Nov 17-18, 2016 Dubai, UAE

International Conference and Exhibition on Medical Writing and Healthcare Communications Nov 17-18, 2016 Dubai, UAE

8th Global Summit and Expo on Healthcare Nov 17-19, 2016 Dubai, UAE

10th International Conference on Clinical & Experimental Ophthalmology Nov 21-23, 2016 Dubai, UAE

13th Global Oncologists Summit and Cancer Therapy Nov 21-23, 2016 Dubai, UAE

International Conference on Intensive and Cricalcare Nursing Nov 21-23, 2016 Dubai, UAE

International Conference on Radiography Nov 21-22, 2016 Dubai, UAE

3rd International Conference on Gynecology & Obstetrics Nov 24-26, 2016 Dubai, UAE

International Pharmaceutical Methods Development and Validation Conference Nov 24-25, 2016 Dubai, UAE

5th International Conference on Petrolium Geology and Petrolium Industry Nov 24-25, 2016 Dubai, UAE

8th International Conference on Clinical Nutrition Nov 24-26, 2016 Dubai, UAE

2nd Global Summit and Expo on Biomass Dec 5-6, 2016 Dubai, UAE

2nd CNS Treatment Dec 5-7, 2016 Dubai, UAE

4th International Conference on Fitness, Health & Wellness Dec 5-6, 2016 Dubai, UAE

International Food Safety, Quality and Policy Conference Dec 5-6, 2016 Dubai, UAE

Burj al-Arab

Burj Khalifa

Sharjah Museum of Islamic Civilisation

Sheikh Zayed Grand Mosque

Dubai Aquarium

Cross your Country Borders! Plan your Trip to UAE

Great Meeting Destination for International Delegates

CNS 2016



Greetings from the MayorGreetings!As Mayor of Phoenix, I take great pride in welcoming all the attendees of the 2nd International Conference on

Parkinson’s Disease and Movement Disorders. Parkinson’s is one of the most common neurological disorders, impacting 15-20 people out of every 100,000.

The number may seem small, but the disease has an immense impact on these families, with annual cost above $10,000 per patient. There are, however, many people working to fight the disease. To help find a cure, the National

Institute of Neurological Disorders and Stroke awarded $90 millionto Parkinson’s disorder research, supported by the National Institute of Health.With approximately 500 neurologists, psychiatrists and neurosurgeons in Phoenix alonededicated to researching and fighting Parkinson’s disease, Phoenix is part of the solution.On behalf of the residents of Phoenix, I welcome you to our city, and wish you a successful conference.

Greg StantonCity Of Phoenix

Office of the MayorPhoenix

Greetings from the Nobel LaureateDear Colleagues, As a Member of the Organizing Committee, I wish to extend a warm welcome to all the participants.

Even though a new era in the history of Parkinson’s disease started with the discovery of the role of dopamine, the introduction of levodopa and an arsenal of dopamine-supporting drugs more than half a century ago, leading to a dramatic improvement in the patients’ quality of life and longevity, the situation for a Parkinson patient is still far from satisfactory, and the need for further research in this disorder is

urgent. Especially, after a varying number of years the presently available drugs start to loose much of their efficiency, with disturbing side effects more and more taking over the scene. I wish to welcome all researchers from the fields of basic neuroscience, neurology, and neurosurgery to contribute with your valuable expertise, and to stimulate interdisciplinary endeavour.

Arvid CarlssonNobel Prize in Physiology/

Medicine for 2000

Greetings from the GovernorGreetings!As Governor of the State of Nevada, it is with great pleasure that I welcome you to participate at OMICS International

Inc. Conferences. The OMICS International through its Open Access initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe. I commend you for having exciting and memorable events filled with enlightening interactive sessions. Thank you for bringing this dynamic exposition to our great state.

As Governor of the great State of Nevada, I would like to express my appreciation to the OMICS International for making this extraordinary conference a possibility.

Brian SandovalOne Hundred One North

Carson StreetCarson City, Nevada 89701

Office: (775) 684-5670Fax No.: (775) 684-5683

Expertise Welcome Messages

Greetings from the Nobel LaureateMy Dear Fellows, We expect that this decade will see great advances in neurosciences. My own work in the area of the

effects of neuro hormones on the brain shows the potential for great strides in this field. Alzheimer’s disease is the most common cause of age-related dementia in the elderly, characterized by memory loss and cognitive decline. Alzheimer’s disease degrades the quality of life of patients, puts a major burden on the family and the caregivers, costs nations around the world billions of dollars annually and has a dismal outcome. Because the people are living longer the number of individuals afflicted with Alzheimer’s disease is

continuing to climb, creating a major global health problem. We must find new ways to treat this devastating disease.

Conferences like this one may help to speed up the development of effective therapies for neurodegenerative diseases like Alzheimer’s disease.

Andrew V SchallyNobel Prize in Physiology/

Medicine for 1977

Greetings from the MayorAs Mayor of London I am delighted to welcome you to the 5th World Congress on Neurology and

Therapeutics which is taking place in London from 14-16 March 2016, organised by OMICS International

Boris JohnsonMayor of London

City Hall, London, SE1 2AA

Neurological disorders including dementia will undoubtedly be one of the most significant challenges in the 21st century and I am pleased that we are hosting such a gathering of eminent experts from London and across the globe at this important event. London has a long and proud history of scientific and

medical research and the conference will give you an excellent opportunity to network with London’s world class leaders.

CNS 2016



Central Nervous System DisordersCentral nervous system disorder is a broad category of conditions in which the brain does not properly function, limiting health and organs functionality. The CNS disorders conditions include the result of damage from brain cancer, degenerative condition, infection, stroke, or problems rose from neurological factors. Meningitis is the neuroinfection or inflammation of the meninges, surrounded by three-layered membranes of the brain, spinal cord and the fluid and immersed in is called as cerebrospinal fluid. Whereas, Encephalitis which is defined as inflammation of the layers of tissue or membranes covering the brain. While the complexity of the central nervous system presents unique challenges for developing novel therapies.

Cognitive NeuroscienceThe field of cognitive neuroscience concerns the scientific study of the neural mechanisms underlying cognition and is a branch of neuroscience. Cognitive neuroscience overlaps with cognitive psychology, and focuses on the neural substrates of mental processes and their behavioral manifestations. Methods employed in cognitive neuroscience include psychophysical experiments, functional neuroimaging, electrophysiological studies of neural systems and, increasingly, cognitive genomics and behavioral genetics. Clinical studies in psychopathology in patients with cognitive deficits constitute an important aspect of cognitive neuroscience.

NeurosurgeryNeurosurgery (or neurological surgery) is the medical specialty concerned with the prevention, diagnosis, treatment, and rehabilitation of disorders which affect any portion of the nervous system including the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system.

Cerebrovascular DisordersCerebrovascular disease is a severe, common and expensive disorder. It is third most frequent cause of death and leading cause of adult disability. Of the 750,000 people suffer stroke annually 170,000 will die due to stroke. The most common forms of cerebrovascular disease are cerebral thrombosis (40% of cases) and cerebral embolism (30%), followed by cerebral haemorrhage.

Brain tumour & ImagingA brain tumor or intracranial neoplasm occurs when abnormal cells form within the brain. There are two main types of tumors: malignant or cancerous tumors and benign tumors. Cancerous tumors can be divided into primary tumors that start within the brain, and secondary tumors that have spread from somewhere else, known as brain metastasis tumors.

Scientific Highlights

CNS 2016



Spinal DisordersSpinal disorder may be seen in individuals irrespective of their age -spina bifida in infants to spinal stenosis in the elderly. There are many types of spinal disorders. The increase in population with spinal disorders has met with a leap in the advancements in diagnostic techniques. X rays, MRI, CT, DEA are some of the commonly used tools in diagnosing spinal disorders.

Neurodegenerative DisordersNeurodegenerative disorder is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. In some cases, the neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration or death of nerve cells. These include Alzheimer’s disease (AD) and other dementias, Parkinson’s disease (PD) and PD-related disorders, Prion disease, Motor neuron diseases (MND), Huntington’s disease (HD), Spinocerebellar ataxia (SCA), Spinal muscular atrophy and others. Each neurodegenerative disease is characterized through its unique aggregated protein. ß-amyloid (Aß) represents as hallmark of Alzheimer’s disease, whereas α-synuclein is the key protein in Parkinson’s disease and Dementia with Lewy bodies (DLB).

Child NeurologyPaediatric neurology evaluates children with disorders of the central and peripheral nervous systems. A large proportion in US population suffers from autism, mental retardation, dyslexia, seizures and other developmental disabilities. Approximately 1,300 U.S children experience severe or fatal brain trauma from child abuse. Epilepsy is the fourth common neurological disorder in the US after migraine, stroke, and Alzheimer’s disease. So there is a need to take into account, the following diseases to dissertate: congenital hydrocephalus, Autism, Neonatal encephalopathy, Paediatrics tumour, Neurodevelopment disorder, Epilepsy and Child psychological disorders.

NeuroimmunologyNeuroimmunology is a field of neuroscience, combining immune system and the nervous system. The immune system administer defence against these organisms, inefficiency of the same results in Infections. The condition is much worse in developing countries; it has been a significant health problem in Australia. Some 350,000 to 500,000 patients suffer from multiple sclerosis (MS) in the United States .The conference on CNS is a platform to put our heads together and thrash out the cause of Multiple sclerosis and auto immune neuropathies, Neuroimmunological infectious disease, Neuromicrobial disorders and Neurological Lyme diseases, Neuroinflamation, Neuroimmuno genetics.

NeuropharmacologyNeuropharmacology means the study of drug effect on the cellular function in the nervous system. Behavioral neuropharmacology and molecular neuropharmacology are the two

CNS 2016



main branches. Behavioral neuropharmacology focus on the study of drugs effect on human behavior (neuropsychopharmacology), including the study of drug dependence and addiction effect on the human brain. Molecular neuropharmacology is the study of neurons and their neurochemical interactions, with the objective of developing drugs that have beneficial effects on neurological function.

Neurochemical TransmissionNeurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules that include psychopharmaceuticals, neuropeptides, or gastrotransmitters that influence the function of neurons. It also deals how these neurochemicals influence the network of neural operation. The studies include micro-macro connection between the analysis of organic compounds active in the nervous system and neural processes such as cortical plasticity, neurogenesis and neural differentiation, synapses, autism and intellectual disability, interneuronal coordination, interaction of drugs and its effect on summation and cotransmission process and advances in astrocyte-neuron interactions in health.

Novel drug development & its effectsDrug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, clinical trials on humans, and may include the step of obtaining regulatory approval to market the drug.

Computational NeurosciencesComputational Neuroscience (CN) is strictly defined as the quantitative understanding of the function of the brain at the level of neuronal dynamics and neural networks. Natural outputs of CN studies are dynamic network models of brain regions or processes that, via computer simulation, provide a theoretical foundation and technology that enhances our understanding of their function.

Case Study on CNSNeurology is a special branch of medical Sciences that deals primarily with the disorders in the central nervous system. Neurophysiology is a union of both neurology and physiology and it studies the functioning of the nervous system.

Clinical Trials on CNSWith an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society. The economic and social costs of neurodegenerative disorders to society are huge. Many big pharmaceutical companies have moved away from CNS research.With this comes the need for new and improved therapies for treating neurodegenerative conditions. From Alzheimer’s to Parkinson’s disease, the target and mechanism by which a disease manifests itself presents unique challenges in how to approach such treatments not to mention ethical and legal issues behind treatment and trial design.

CNS 2016



CNS BiomarkersA biomarker can be defined as a biological variable that has a statistically significant relationship with parameters of disease states or the activity of a drug or drug candidate. Biomarkers are fast becoming an essential part of clinical development, largely because they: (i) offer the prospect of more homogenous patient populations in clinical trials through patient selection and stratification; (ii) permit assessment of target engagement; (iii) allow the consequences of target engagement to be measured; and (iv) provide markers of disease modification.

Neurological NursingNeurological Nursing is a very challenging nursing specialty dealing with assessment, nursing diagnosis, and management of many neurological disorders for which nurses provide patient care. This includes trauma, brain injuries, stroke, seizures, tumors, headaches, infections, and aneurysms, as well as a host of other neurological complexities.

CNS 2016



CNS 2016



CNS 2016



Central Nervous System-2012 Report

The International Conference & Exhibition on Central Nervous System - Drug Effects & Novel Drug Development, hosted by the OMICS Group was held on September 05-07, 2012 at Double Tree by Hilton Philadelphia Center City, USA. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from neurologists, researchers and leaders from pharma, government organizations who made this conference as one of most successful and productive events in 2012 from OMICS Group.

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks

• Alzheimer’s Disease• Disorders related to CNS• Behavioral Neurology• Clinical Neurophysiology• Oncology of Central Nervous System• Neurodegenerative Diseases• Remedies for CNS & Neurological Disorders• CNS Biomarkers• Clinical Trials on CNS• Drug Metabolism in Drug Design and Drug Interactions• Neural Stem Cells and Gene or Cell Therapy• Neuroimmunology• Neuromics & Human Brain proteome• Perspectives in Neurology Research• Neurorehabilitation• Epilepsy• Cerebral CSF Flow Studies• Diagnosis for cerebral infectionsThe conference was initiated with a prominent keynote speaker, Dr. Giulio Maria Pasinetti from Mount Sinai School of Medicine, USA, The above mentioned keynote speaker gave his energetic and fruitful contributions at Central Nervous System-2012.

All accepted abstracts have been indexed in OMICS Group Journal of Neurology & Neurophysiology as a special issue.

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Central Nervous System -2012, and with their unique feedback, OMICS Group would like to announce the “2nd International Conference on Central Nervous System disorders and Therapeutics” to be held at Dubai, UAE on December 05-07, 2016.

Past Conference Report

CNS 2016



• Central nervous system tumors are the most common cancers among children ages 0-19.

• The majority of primary tumors (34%) are located within the meninges, followed by those located within the frontal, temporal, parietal and occipital lobes of the brain (22%).

• In 2006-2010, the average annual age-adjusted incidence rate of all primary malignant brain and CNS tumors was 7.27 & the average annual age-adjusted incidence rate of non-malignant brain and CNS tumors was 13.77.

• Glioblastomas represent 17% of all primary brain tumors, and 54% of all gliomas.

• CNS and brain tumours were the ninth most common cancer in the UK (2012), accounting for 3% of all new cases. They are the 11th most common cancers in males (3% of the male total) and the eighth most common in females (3%).

• In 2012, 9,678 new brain, other CNS and intracranial tumour cases were registered in the UK 4,760 (49%) in men and 4,918 (51%) in women, giving a male:female ratio of around 10:10. The crude incidence rate shows that there are 15 new brain, other CNS and intracranial tumour cases for every 100,000 males in the UK and 15 for every 100,000 females.

• Advanced radiation therapy techniques that target tumor tissue more precisely and reduce radiation damage to surrounding normal tissue (such as 3-dimensional conformal therapy, stereotactic radiation therapy, and intensity-modulated radiation therapy) are being refined.

• A new scale developed by NIH, which is based on tumor size, tumor location, and a patient’s ability to perform everyday tasks, can help surgeons identify which patients with glioblastoma will benefit from additional surgery when their tumor recurs.

• In 2008, The Cancer Genome Atlas (TCGA) project reported the first results of its large-scale, comprehensive study of gene changes in glioblastoma (a type of glioma). These results identified three previously unrecognized mutations that occur frequently in glioblastoma and three cell-signaling pathways that may help drive tumor growth. The results also shed new light on molecular mechanisms that may make tumors resistant to some chemotherapy drugs. In 2010, additional results from TCGA showed that glioblastoma comprises four different molecular subtypes that have different responses to chemotherapy and radiation therapy.

• Despite tremendous advances in our understanding of brain cancer biology, substantial progress in brain tumor diagnosis and treatment, and marked improvements in the quality of life of brain tumor patients, the mortality rate for brain and other CNS cancers has remained largely unchanged over the past 30 to 40 years.

CNS Market Statistics

CNS 2016



Dubai is the most populated city in the UAE with residents of 2.2 million. Dubai is global business city and cultural hub of the Middle East and the Persian Gulf region. It is one of the countries of MENA which has international network of research with higher-education Institutions, transport, business, communication, events and conference hub bridging healthcare professionals from the seven continents annually to collaborate and exchange knowledge and research.

Dubai’s attraction lies in the contrast between the ultra-modern and the enchantingly traditional, which gives the city a personality like no other and visitors a variety of experiences to choose from. From desert oases and unspoiled beaches, camel races and old wind towers, to top-class shopping opportunities, avant-garde architecture and the finest international cuisine, Dubai has more than enough depth to satisfy even the most seasoned of travellers.

Why Dubai??

• Dubai is the most populated city in the UAE with residents of 2.2 million. Dubai is global business city and cultural hub of the Middle East and the Persian Gulf region.

• Dubai is place of eventsand conference hub bridging healthcare professionals from the seven continents annually to collaborate and exchange knowledge and research.

• Dubai is an upcoming global leader in medical innovation and research.

• The medical tourism is expected to attract more than 500,000 patients per year and boost its economy by up to $2.6 billion by 2020.

• It is one of the countries of MENA which has international network of research with higher-education Institutions, transport, business and communication.

• Air flights take 14 hours from US, 5hours from Europe and 3hours from most parts of the Middle East and Asia.

• Dubai won the bid to host EXPO 2020, a Universal scale Registered Exposition approved by the Bureau of International Expositions (BIE), Paris

About Dubai, UAE

Important DatesAbstract submission opens: December 10, 2015Registration opens: December 10, 2015Early bird registration: February 10, 2016On spot registration: December 05, 2016

CNS 2016


VenueDubai, UAE

Register online: http://cns.conferenceseries.com/registration.php

Registration Benefits• Contribute to and learn about the most recent advances in Neurology field • Accepted abstract will be published in respective OMICS journals • Each abstract will receive a Digital Object Identifier (DOI) provided by crossref • Conference will contribute to increment in overall research profile • Golden chance to meet other researchers in neurology field and potential contacts for future positions • International platform for presentation skills and expertise to discuss the research in clear and meaningful way


Important Links

CNS 2016


Special Issues All accepted abstracts will be published in respective OMICS International Journals

Each abstract will be provided with digital Object Identifier by

About Us


OMICS International Journals • 700+ Open Access Journals • Scholarly Journals Index- PubMed, ISI, Scopus,

Chemical Abstracts Service, ProQuest, Gale EBSCO • 21 Days rapid review process• 70000 Editorial Team• Publication immediately after acceptance• Quality and quick editorial, review processing

Key features • User friendly/feasible website translation of your

paper to 50 world’s leading languages• Enhanced feature: Audio version of published paper• Digital articles to share and explore• Sharing option: Social networking enabled• Authors, reviewers and editors are provided with

scientific credits

OMICS International Conferences • 3000+ Global Events with over 600+ Conferences,

1200+ Symposiums and 1200+ Workshops• 15 Million unique visitors/year (36 million page

views/year)• Well organized scientific program• Renowned speakers and scientists across the

globe• Poster presentations and world class exhibits• Panel discussions and interactive sessions• B2B meetings• Perfect platform for Global Networking

Key features • Presentation by renowned speakers from all over

the world• Poster presentations and world class exhibits• Interactive Sessions• Live Streaming Conferences and Meetings• Platform for global networking• Connecting scientific community

CNS 2016


CNS 2016 aims to fasten the advancement of scientific knowledge that may ultimately result in a better prognosis for patients. International conference is the best platform to develop new partnership & collaborations .It provides an important base for the exchange of knowledge and experience amongst the clinicians. The internationally renowned speakers at this conference will explore the various aspects of Central Nervous System disorders and Therapeutics.CNS 2016• Opportunity to attend the presentations delivered by eminent scientists from all over the world

• Selected contributions will be published in following OMICS International Journals• Current Neurobiology• Journal of Neurological Disorders• Journal of Neurology and Neuroscience• Journal of Neurology & Neurophysiology

• Participation in sessions on specific topics on which the conference is expected to achieve progress

• Global networking: In transferring and exchanging Ideas

• Conference brings together Scientific Researchers, Safety Professionals, Regulatory Authorities, Principal Investigators, Business Entrepreneurs, and Industry Developers.


Date post:	13-Apr-2017
Category:	Documents
Upload:	alberto-kent
View:	50 times
Download:	2 times

CNS 2016_Brochure-ilovepdf-compressed

Documents